March is #AutoimmuneAwareness Month, a time to shed light on the millions of people worldwide affected by these conditions. Join us in supporting those living with these conditions and advancing research and treatments. Read more about Sonoma Biotherapeutics’ approach to developing #Treg #celltherapies for #autoimmunediseases here: https://bit.ly/3TNmN3J
Sonoma Biotherapeutics
Biotechnology Research
South San Francisco, California 15,119 followers
Leading the Next Frontier of Cell Therapy
About us
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.
- Website
-
https://www.sonomabio.com
External link for Sonoma Biotherapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
- Specialties
- cell therapy and autoimmune disease
Locations
-
Primary
Get directions
201 Haskins Way
South San Francisco, California 94080, US
-
Get directions
410 W Harrison St
Seattle, Washington 98119, US
Employees at Sonoma Biotherapeutics
Updates
-
Last week, members of the #OneSonoma team gathered at the Stand Up for Science rallies in San Francisco and Seattle, joined by our fearless leader Jeffrey Bluestone. We were proud to march alongside fellow scientists, advocates and community members to celebrate science and its critical role in our day-to-day lives. #StandUpForScience
-
-
Happy #InternationalWomensDay from all of us at Sonoma Biotherapeutics! We are proud to highlight some of the amazing emerging female leaders here at Sonoma. We believe that we can only achieve our mission of developing #Treg #celltherapies to cure #autoimmunedisease by relying on the collaboration of many people with diverse perspectives. #OneSonoma #IWD2025
-
-
On this Employee Appreciation Day, we celebrate all of our hardworking and passionate colleagues here at Sonoma Biotherapeutics. We thank them for showing up every day as a dedicated team to execute our mission of developing #Treg therapies to cure #autoimmune disease. #EmployeeAppreciationDay #OneSonoma #CellTherapy
-
-
We're #hiring across our Clinical Development and Chemistry, Manufacturing and Controls (CMC) teams! Interested in joining our collaborative, science-driven team of innovators dedicated to developing #Treg #celltherapy for patients with #autoimmune diseases? Learn more and apply: https://bit.ly/3ScM4CN #ClinicalDevelopment #MedicalDirector #ProjectManagement #CMC #ChemistryJobs #HybridRole #RemoteOpportunity
-
-
We’re excited to share that our Chief Scientific Officer, Joe Arron, M.D., Ph.D., was featured in an Inside Precision Medicine article, discussing Sonoma Biotherapeutics’ unique approach to treating and possibly curing #autoimmune diseases through engineered regulatory T cells (Tregs). Read it here: https://bit.ly/4gLlon0 #Treg #CellTherapy
-
-
On this International Day of Women and Girls in Science, we celebrate the fantastic women at Sonoma Biotherapeutics and express our gratitude for their incredible contributions to our mission to design, develop and deliver therapies to cure #autoimmune disease and prolong healthy life. #IDWGS #WomenInSTEM #OneSonoma #Treg #CellTherapy
-
-
Today, on #WearRedDay, we’re sharing reflections from our Chief Financial Officer, Jessica Stitt. Thank you for your recognition of this important cause, Jessica! #WomensHeartHealth #HeartMonth
Today is Wear Red Day, an opportunity to create a conversation around women’s heart health and disease prevention, education and support. Heart disease remains the leading cause of death for women in the U.S., yet it often goes unnoticed until it’s too late. According to the CDC, in 2021, heart disease was responsible for about 1 in every 5 female deaths.* Many women don’t realize their risk until it’s critical, and those with autoimmune diseases like rheumatoid arthritis face even greater risks. That is why I am proud to support WomenHeart: The National Coalition for Women with Heart Disease, the first and only national patient-centered organization solely focused on supporting women with or at risk of heart disease. Learn more about their mission: https://lnkd.in/egfJSg6m #WearRedDay #WomensHeartHealth #HeartMonth #AutoimmuneDisease *Source: https://lnkd.in/eF7d5ffr
-
-
We are thrilled to have Katharine (Katie) Miller join Sonoma as VP of Quality. Katie’s impressive 30+ years of industry experience aiding in the development and commercialization of therapeutics will make her an invaluable addition to the team. Welcome, Katie! #OneSonoma #AutoimmuneDisease #Qualitybydesign #QualityAssurance #Celltherapy #Tregs #CMC #Celltherapymanufacturing
-
-
Today marks Rheumatoid Arthritis (RA) Awareness Day, a time to promote awareness and understanding of this difficult disease. Sonoma is committed to developing treatment options for people living with #RA and other #autoimmune diseases. Learn more about our Regulate-RA clinical trial for adults living with RA in the U.S.: https://lnkd.in/et3wbdF2 #RheumAwarenessDay
-